Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
T Osaki
Observed name:
T. Osaki
Institutions:
University of Occupational and Environmental Health Japan,
Kitakyushu Municipal Medical Center,
ShinKokura Hospital,
Fukuoka Wajiro Hospital,
Niigata Rosai Hospital
Observed institutions:
Kyushu University,
University of Occupational and Environmental Health Japan,
Ruhrlandklinik,
Kitakyushu Municipal Medical Center,
ShinKokura Hospital,
Fukuoka Wajiro Hospital,
Niigata Rosai Hospital
show all 7
OpenAlex ID:
A5113579000
Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer
1993
·
T. Mitsudomi
, T. Oyama
, et al.
·
JNCI Journal of the National Cancer Institute
·
208
Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.
2001
·
K Shibahara
, K Sugio
, et al.
·
PubMed
·
171
p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival
1995
·
T. Mitsudomi
, T. Oyama
, et al.
·
Annals of Oncology
·
64
Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence
2004
·
C Gu
, T Oyama
, et al.
·
British Journal of Cancer
·
53
PDF
Fas expression in non-small cell lung cancer
1999
·
H Uramoto
, T Osaki
, et al.
·
European Journal of Cancer
·
47
Pleural retraction and intra-tumoral air-bronchogram as prognostic factors for stage I pulmonary adenocarcinoma following complete resection.
2000
·
I Yoshino
, R Nakanishi
, et al.
·
PubMed
·
26
A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung
1994
·
S Hosoe
, K Ueno
, et al.
·
Lung Cancer
·
20
Chronic expanding hematoma in the chest.
2000
·
H Uramoto
, R Nakanishi
, et al.
·
PubMed
·
19
Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
2000
·
T Oyama
, T Osaki
, et al.
·
PubMed
·
17
Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non-small cell lung cancer
1995
·
T. Oyama
, T. Mitsudomi
, et al.
·
Surgical Oncology
·
15
Increased levels of serum intercellular adhesion molecule-1 (ICAM-1) in patients with non-small cell lung cancer
1996
·
T. Osaki
, T. Mitsudomi
, et al.
·
Surgical Oncology
·
12
p53 mutations of lung cancer are not significantly affected by CYP1A1 or GSTM1 polymorphisms
1997
·
T Oyama
, T Kawamoto
, et al.
·
International Journal of Oncology
·
11
Combined thoracoscopy and mediastinoscopy for the evaluation of mediastinal lymph node metastasis in left upper lobe lung cancer
1995
·
R Nakanishi
, T Mitsudomi
, et al.
·
Lung Cancer
·
10
Mesenteric neurofibroma with von Recklinghausen's disease: a case report.
1998
·
K Yano
, T Okamura
, et al.
·
PubMed
·
9
Results of resection for bronchogenic carcinoma in patients over the age of 80
1994
·
T. Shirakusa
, T. Kusano
, et al.
·
Lung Cancer
·
8
Surgical resection for pulmonary metastases of sweat gland carcinoma.
1994
·
T Osaki
, M Kodate
, et al.
·
Thorax
·
7
PDF
Generation of a small cell lung cancer variant resistant to lymphokine-activated killer (LAK) cells: association with resistance to a LAK cell-derived, cytostatic factor.
1992
·
I Tachibana
, M Watanabe
, et al.
·
PubMed
·
4
[Assessment of prognosis and p 53 mutations in patients with multiple tumors of the lung; intrapulmonary metastasis or double primary cancers?].
2002
·
T Osaki
, T Oyama
, et al.
·
PubMed
·
2
[Panpleuropneumonectomy for primary lung cancer patients with pleural dissemination].
1992
·
K Dobashi
, H Nakahashi
, et al.
·
PubMed
·
2
P-098 Cytochrome P450 2A6 and 3A expression in non-small cell lung cancer
2005
·
T. Oyama
, K. Sugio
, et al.
·
Lung Cancer
·
1
HLA frequency and prognosis in non-small cell lung carcinoma
2000
·
T So
, M Takenoyama
, et al.
·
Lung Cancer
·
1
[Evaluation of results following thymectomy in myasthenia gravis].
1993
·
T Osaki
, T Shirakusa
, et al.
·
PubMed
·
1
Randomized phase II trial of the biweekly schedule of adjuvant chemotherapy with carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with non-small cell lung cancer (NSCLC)
2009
·
K. Sugio
, A. Nagashima
, et al.
·
Journal of Clinical Oncology
N-Acetylation polymorphism as a risk factor for lung adenocarcinoma; In relation to p53 gene mutation
2000
·
T Oyama
, T Osaki
, et al.
·
Lung Cancer
Interleukin-12 enhances the antitumor activity of cytotoxic T lymphocytes against lung adenocarcinoma engrafted in severe combined immunodeficient mice
2000
·
T. Hanagiri
, S. Imahayashi
, et al.
·
International Journal of Clinical Oncology
Show more works
View as search
Works count:
32
Citation count:
708
H-index:
11
I10-index:
13
Year
Topic
Type
